- Home
- DWTX
as 04-24-2025 12:35pm EST
Stocks
Dogwood Therapeutics Inc formerly Virios Therapeutics Inc is a development-stage biotechnology company. It is focused advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (FM) and Long-COVID (LC). Its product candidates includes IMC-1 and IMC-2, IMC-1, is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | ALPHARETTA |
| Market Cap: | 5.9M | IPO Year: | N/A |
| Target Price: | $10.00 | AVG Volume (30 days): | 2.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -12.52 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.62 - $29.28 | Next Earning Date: | 05-14-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest DOGWOOD THERAPEUTICS INC News
DWTX Breaking Stock News: Dive into DWTX Ticker-Specific Updates for Smart Investing
GlobeNewswire
13 days ago
Dogwood Therapeutics, Inc. Receives Nasdaq Confirmation of Compliance
Zacks Small Cap Research
20 days ago
DWTX: Interim Data for Phase 2b Trial in 4Q25…
GlobeNewswire
21 days ago
Dogwood Therapeutics, Inc. Regains Nasdaq Compliance
GlobeNewswire
24 days ago
Dogwood Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results
MT Newswires
a month ago
Dogwood Therapeutics Begins Dosing in Mid-Stage Study of Halneuron for Chemotherapy-Related Neuropathic Pain
GlobeNewswire
a month ago
Dogwood Therapeutics Announces Dosing of First Patient in Phase 2b Trial Evaluating Halneuron® in Patients with Chemotherapy-Induced Neuropathic Pain
Zacks Small Cap Research
a month ago
DWTX: First Patient Dosed in Phase 2b Trial of Halneuron in CINP; Debt Conversion Strengthens Balance Sheet…
TipRanks
a month ago
Biotech Alert: Searches spiking for these stocks today
Compare DWTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DWTX DOGWOOD THERAPEUTICS INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.